Stephanie Feldstein, MD
Dermatology · La Mesa
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Offices
- 2
Offices
2 locations · Southern California Permanente Medical Group · 11,250 clinicians in this group
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Feldstein’s office at (619) 528-5000 to ask if they take your plan before you enroll.
California Medical Board record
Licence A146480 · Current
Licensed to practise in California · since 2016 · expires 2028-01-31 · University of California, San Diego School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Original Medicare doctor bills
$1,341
Medicare paid this office $1,341 for 11 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
Procedures Medicare counted
| Skin biopsy | 1-10 | None |
Who their Medicare patients are
11 Original Medicare patients in 2024. Average age 71 · Health risk score 1.71. Sicker patients than 9 in 10 peers; the typical dermatology clinician is at 1.01.
The office billed $7,209, Medicare allowed $2,492 and paid $1,341; for 38 services of 13 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 11 | 38 | 71 | 1.71 | $7,209 | $1,341 |
| 2023 | 20 | 56 | 70 | 1.38 | $8,697 | $1,980 |
| 2022 | 15 | 47 | 69 | 0.87 | $9,544 | $2,253 |
| 2021 | 13 | 63 | 70 | 1.79 | $8,822 | $1,821 |
| 2020 | 17 | 42 | 68 | 1.35 | $8,252 | $1,529 |
| 2019 | 47 | 164 | 71 | 0.94 | $20,520 | $8,561 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2019: 5 services
| Short return visit (20+ min) | 20 | $1,308 | $62 |
| Return visit (30+ min) | 13 | $1,183 | $91 |
| Biopsy of related skin growth, first growth | 12 | $937 | $78 |
| Destruction of precancer skin growth, 1 growth | 17 | $749 | $42 |
| Destruction of precancer skin growth, 2-14 growths | 15 | $277 | $5 |
Medicaid work
$1,400 in 2023
Medicaid paid $1,400 for 41 billed services this clinician did in 2023, up to 12 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Actinotherapy (ultraviolet light) | 41 | $1,400 |
| 2023 | 41 | 1 | 12 | $1,400 |
| 2021 | 27 | 1 | 15 | $685 |
| 2020 | 26 | 1 | 14 | $553 |
See the largest Medicaid services in earlier years
2021
| Short return visit (20+ min) | 27 | $685 |
2020
| OFFICE/OUTPATIENT NEW SF MDM 15 MINUTES | 26 | $553 |
Drugs they prescribed that Part D paid
$580,121
Pharmacies billed $580,121 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 1,868) in 2024. At or below the middle of the specialty; the typical dermatology clinician is at 0%.
1,605 generic and 263 brand-name prescriptions · $580,121 in drug cost · 87 antibiotic prescriptions to 48 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Cosentyx Sensoready (2 Pens) | 43 | $188,359 | $4,380 |
| Humira | 12 | $81,725 | $6,810 |
| Dupixent | 17 | $64,521 | $3,795 |
| Otezla | 14 | $62,106 | $4,436 |
| Fluorouracil | 308 | $12,611 | $41 |
See all 32 drugs
| Cosentyx Sensoready (2 Pens) | 43 | $188,359 | $4,380 |
| Humira | 12 | $81,725 | $6,810 |
| Dupixent | 17 | $64,521 | $3,795 |
| Otezla | 14 | $62,106 | $4,436 |
| Fluorouracil | 308 | $12,611 | $41 |
| Vectical | 65 | $12,314 | $189 |
| Clobetasol Propionate | 320 | $7,954 | $25 |
| Calcipotriene | 52 | $5,797 | $111 |
| Tacrolimus | 73 | $5,517 | $76 |
| Doxycycline Monohydrate | 80 | $2,784 | $35 |
| Triamcinolone Acetonide | 107 | $2,724 | $25 |
| Retin-A | 72 | $2,674 | $37 |
| Acitretin | 19 | $2,043 | $108 |
| Hydrocortisone | 83 | $1,387 | $17 |
| Imiquimod | 35 | $972 | $28 |
| Ketoconazole | 51 | $946 | $19 |
| Valacyclovir | 24 | $894 | $37 |
| Doxycycline Hyclate | 20 | $868 | $43 |
| Nystatin | 21 | $686 | $33 |
| Betamethasone Diprop Augmented | 18 | $679 | $38 |
| Metronidazole | 32 | $678 | $21 |
| Terbinafine | 27 | $664 | $25 |
| Mupirocin | 33 | $648 | $20 |
| Hydroxychloroquine Sulfate | 15 | $638 | $43 |
| Fluocinolone Acetonide | 22 | $604 | $27 |
| Gabapentin | 24 | $466 | $19 |
| Methotrexate | 27 | $452 | $17 |
| Clindamycin Phosphate | 13 | $345 | $27 |
| Minoxidil | 24 | $291 | $12 |
| Hydroxyzine | 37 | $255 | $7 |
| Finasteride | 17 | $166 | $10 |
| Fluconazole | 13 | $131 | $10 |
Year by year
| 2024 | 1,868 | 682 | 0% (0) | 14% | $580,121 |
| 2023 | 1,930 | 765 | 0% (0) | None | $509,237 |
| 2022 | 1,291 | 551 | 0% (0) | 20% | $385,210 |
| 2021 | 1,579 | 647 | 0% (0) | 19% | $303,158 |
| 2020 | 797 | 387 | 0% (0) | 14% | $151,600 |
| 2019 | 154 | 66 | 0% (0) | 18% | $112,560 |
| 2018 | 267 | 114 | 0% (0) | 19% | $159,623 |
| 2017 | 271 | 108 | 0% (0) | 25% | $253,956 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 27 drugs
| Cosentyx Sensoready (2 Pens) | 61 | $285,595 | $4,682 |
| Vectical | 101 | $16,026 | $159 |
| Fluorouracil | 359 | $15,538 | $43 |
| Clobetasol Propionate | 335 | $8,911 | $27 |
| Tacrolimus | 85 | $5,814 | $68 |
| Retin-A | 89 | $3,595 | $40 |
| Doxycycline Monohydrate | 113 | $3,565 | $32 |
| Triamcinolone Acetonide | 103 | $2,859 | $28 |
| Acitretin | 20 | $2,247 | $112 |
| Betamethasone Diprop Augmented | 36 | $1,385 | $38 |
| Hydrocortisone | 83 | $1,341 | $16 |
| Valacyclovir | 32 | $1,151 | $36 |
| Imiquimod | 33 | $960 | $29 |
| Ketoconazole | 53 | $868 | $16 |
| Metronidazole | 37 | $595 | $16 |
| Fluocinolone Acetonide | 16 | $571 | $36 |
| Fluocinolone Acetonide | 18 | $542 | $30 |
| Hydroxychloroquine Sulfate | 13 | $511 | $39 |
| Mupirocin | 37 | $474 | $13 |
| Methotrexate | 33 | $462 | $14 |
| Glycopyrrolate | 11 | $443 | $40 |
| Terbinafine | 21 | $402 | $19 |
| Clindamycin Phosphate | 17 | $374 | $22 |
| Fluconazole | 20 | $205 | $10 |
| Minoxidil | 21 | $204 | $10 |
| Prednisone | 12 | $202 | $17 |
| Hydroxyzine | 21 | $142 | $7 |
2022: 22 drugs
| Cosentyx Pen (2 Pens) | 30 | $144,659 | $4,822 |
| Vectical | 163 | $25,139 | $154 |
| Fluorouracil | 214 | $12,154 | $57 |
| Clobetasol Propionate | 204 | $6,959 | $34 |
| Tacrolimus | 49 | $4,935 | $101 |
| Retin-A | 37 | $2,733 | $74 |
| Triamcinolone Acetonide | 78 | $2,025 | $26 |
| Doxycycline Monohydrate | 39 | $1,334 | $34 |
| Betamethasone Diprop Augmented | 31 | $1,190 | $38 |
| Hydrocortisone | 75 | $1,153 | $15 |
| Desoximetasone | 12 | $1,110 | $92 |
| Valacyclovir | 18 | $773 | $43 |
| Metronidazole | 32 | $733 | $23 |
| Fluocinolone Acetonide | 17 | $518 | $30 |
| Mupirocin | 36 | $511 | $14 |
| Fluocinonide | 16 | $511 | $32 |
| Ketoconazole | 14 | $339 | $24 |
| Terbinafine | 14 | $246 | $18 |
| Fluconazole | 17 | $195 | $11 |
| Prednisone | 11 | $132 | $12 |
| Methotrexate | 12 | $106 | $9 |
| Hydroxyzine | 14 | $93 | $7 |
2021: 22 drugs
| Cosentyx Pen (2 Pens) | 18 | $72,371 | $4,021 |
| Vectical | 213 | $31,667 | $149 |
| Clobetasol Propionate | 248 | $17,889 | $72 |
| Fluorouracil | 279 | $16,569 | $59 |
| Tacrolimus | 48 | $3,887 | $81 |
| Triamcinolone Acetonide | 133 | $3,550 | $27 |
| Betamethasone Diprop Augmented | 32 | $2,737 | $86 |
| Doxycycline Monohydrate | 83 | $2,262 | $27 |
| Retin-A | 23 | $1,741 | $76 |
| Hydrocortisone | 95 | $1,585 | $17 |
| Mupirocin | 79 | $1,447 | $18 |
| Dapsone | 12 | $1,426 | $119 |
| Metronidazole | 29 | $954 | $33 |
| Valacyclovir | 20 | $654 | $33 |
| Imiquimod | 18 | $602 | $33 |
| Fluocinonide | 12 | $520 | $43 |
| Clindamycin Phosphate | 16 | $389 | $24 |
| Ketoconazole | 18 | $374 | $21 |
| Prednisone | 14 | $240 | $17 |
| Fluconazole | 16 | $212 | $13 |
| Terbinafine | 13 | $151 | $12 |
| Hydroxyzine | 20 | $128 | $6 |
2020: 17 drugs
| Vectical | 46 | $6,808 | $148 |
| Betamethasone Diprop Augmented | 85 | $5,634 | $66 |
| Pimecrolimus | 21 | $5,525 | $263 |
| Fluorouracil | 82 | $5,192 | $63 |
| Clobetasol Propionate | 88 | $5,068 | $58 |
| Triamcinolone Acetonide | 70 | $1,877 | $27 |
| Tacrolimus | 18 | $1,723 | $96 |
| Doxycycline Monohydrate | 46 | $1,484 | $32 |
| Fluocinonide | 12 | $1,048 | $87 |
| Mupirocin | 55 | $963 | $18 |
| Metronidazole | 20 | $772 | $39 |
| Clindamycin Phosphate | 25 | $703 | $28 |
| Hydrocortisone | 28 | $457 | $16 |
| Valacyclovir | 17 | $349 | $21 |
| Terbinafine | 20 | $316 | $16 |
| Ketoconazole | 13 | $279 | $21 |
| Prednisone | 12 | $188 | $16 |
2019: 5 drugs
| Clobetasol Propionate | 36 | $6,561 | $182 |
| Doxycycline Hyclate | 12 | $773 | $64 |
| Triamcinolone Acetonide | 17 | $426 | $25 |
| Ketoconazole | 13 | $383 | $29 |
| Hydroxyzine | 11 | $53 | $5 |
2018: 8 drugs
| Clobetasol Propionate | 52 | $4,737 | $91 |
| Fluorouracil | 16 | $2,000 | $125 |
| Fluocinonide | 13 | $1,596 | $123 |
| Doxycycline Hyclate | 12 | $635 | $53 |
| Triamcinolone Acetonide | 17 | $394 | $23 |
| Ketoconazole | 13 | $209 | $16 |
| Mupirocin | 11 | $102 | $9 |
| Prednisone | 15 | $69 | $5 |
2017: 5 drugs
| Clobetasol Propionate | 38 | $6,775 | $178 |
| Desonide | 11 | $1,683 | $153 |
| Fluocinonide | 15 | $1,636 | $109 |
| Ketoconazole | 14 | $484 | $35 |
| Triamcinolone Acetonide | 21 | $446 | $21 |
Money from drug and device companies
$443 in 2019
A payment is not proof that care is biased.
| Ortho Dermatologics a division of Bausch Health US | Altreno | $224 | 4 payments
|
| Allergan | None | $97 | 1 payment
|
| Dermira | None | $46 | 1 payment
|
| Galderma Laboratories L.P. | None | $39 | 2 payments
|
| Pfizer | Eucrisa | $23 | 1 payment
|
| Lilly USA | Taltz | $14 | 1 payment
|
See all 10 published payments
| Galderma Laboratories L.P. | Meals · 2019-11-27 | None | $24 |
| Ortho Dermatologics a division of Bausch Health US | Meals · 2019-11-12 | Altreno | $5 |
| Pfizer | Meals · 2019-11-09 | Eucrisa | $23 |
| Galderma Laboratories L.P. | Meals · 2019-10-30 | None | $15 |
| Lilly USA | Meals · 2019-09-20 | Taltz | $14 |
| Dermira | Meals · 2019-08-20 | None | $46 |
| Ortho Dermatologics a division of Bausch Health US | Meals · 2019-04-27 | Altreno | $30 |
| Allergan | Meals · 2019-03-02 | None | $97 |
| Ortho Dermatologics a division of Bausch Health US | Meals · 2019-01-20 | Altreno | $98 |
| Ortho Dermatologics a division of Bausch Health US | Meals · 2019-01-19 | Siliq | $92 |
Professional record
- NPI
- 1528453701
- Licence
- CA A146480California A146480: Current · expires 2028-01-31
- Trained
- University of California, San Diego School of Medicine, 2015
- Gender
- Female
More record details
- Sole proprietor
- Yes
- Taxonomy
- Federal specialty code 207N00000X (207N00000X); Student in a training program (390200000X)
- Mailing address
- 3301 C St Ste 1400, Sacramento, CA, 95816
- NPI first listed
- 2015-04-03
- NPI last updated
- 2021-12-07
- NPI record certified
- 2021-12-07
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 751 S Bascom Ave, San Jose, CA, 95128
This office lists an electronic records connection.